Jennings Emily, De Lusignan Simon, Michalakidis Georgios, Krause Paul, Sullivan Frank, Liyanage Harshana, Delaney Brendan
Hon. Research Assistant.
University of Surrey.
J Innov Health Inform. 2018 Dec 31;25(4):207-220. doi: 10.14236/jhi.v25i4.964.
The Translational Research and Patients safety in Europe (TRANSFoRm) project aims to integrate primary care with clinical research whilst improving patient safety. The TRANSFoRm International Research Readiness survey (TIRRE) aims to demonstrate data use through two linked data studies and by identifying clinical data repositories and genetic databases or disease registries prepared to participate in linked research.
The TIRRE survey collects data at micro-, meso- and macro-levels of granularity; to fulfil data, study specific, business, geographical and readiness requirements of potential data providers for the TRANSFoRm demonstration studies. We used descriptive statistics to differentiate between demonstration-study compliant and non-compliant repositories. We only included surveys with >70% of questions answered in our final analysis, reporting the odds ratio (OR) of positive responses associated with a demonstration-study compliant data provider.
We contacted 531 organisations within the Eurpean Union (EU). Two declined to supply information; 56 made a valid response and a further 26 made a partial response. Of the 56 valid responses, 29 were databases of primary care data, 12 were genetic databases and 15 were cancer registries. The demonstration compliant primary care sites made 2098 positive responses compared with 268 in non-use-case compliant data sources [OR: 4.59, 95% confidence interval (CI): 3.93-5.35, p < 0.008]; for genetic databases: 380:44 (OR: 6.13, 95% CI: 4.25-8.85, p < 0.008) and cancer registries: 553:44 (OR: 5.87, 95% CI: 4.13-8.34, p < 0.008).
TIRRE comprehensively assesses the preparedness of data repositories to participate in specific research projects. Multiple contacts about hypothetical participation in research identified few potential sites.
欧洲转化研究与患者安全(TRANSFoRm)项目旨在将初级保健与临床研究相结合,同时提高患者安全。TRANSFoRm国际研究准备情况调查(TIRRE)旨在通过两项关联数据研究以及识别准备参与关联研究的临床数据存储库、基因数据库或疾病登记处来展示数据的使用情况。
TIRRE调查在微观、中观和宏观层面收集数据;以满足TRANSFoRm示范研究潜在数据提供者的数据、研究特定、业务、地理和准备情况要求。我们使用描述性统计来区分符合示范研究和不符合示范研究的存储库。我们仅在最终分析中纳入回答问题比例超过70%的调查,报告与符合示范研究的数据提供者相关的积极回应的优势比(OR)。
我们联系了欧盟境内的531个组织。两个组织拒绝提供信息;56个组织给出了有效回复,另有26个组织给出了部分回复。在56个有效回复中,29个是初级保健数据数据库,12个是基因数据库,15个是癌症登记处。符合示范研究的初级保健站点给出了2098个积极回应,而不符合用例的数据来源给出了268个积极回应[OR:4.59,95%置信区间(CI):3.93 - 5.35,p < 0.008];基因数据库方面:380:44(OR:6.13,95%CI:4.25 - 8.85,p < 0.008),癌症登记处方面:553:44(OR:5.87,95%CI:4.13 - 8.34,p < 0.008)。
TIRRE全面评估了数据存储库参与特定研究项目的准备情况。关于假设参与研究的多次联系发现潜在站点很少。